Xevant's AI Platform Earns Top Healthcare Innovation Award

LEHI, Utah – January 29, 2026 – In a significant validation for the role of artificial intelligence in managing spiraling healthcare costs, Lehi-based Xevant has been named a 2025 Modern Healthcare Best in Business company. The firm, a leader in real-time pharmacy benefits intelligence, secured the honor in the highly competitive Artificial Intelligence (AI) category, recognizing its tangible impact on the healthcare ecosystem throughout 2025.

The award from Modern Healthcare, a premier source for industry news and information, celebrates suppliers and technology partners whose innovations are reshaping healthcare delivery and operations. This recognition places Xevant among an elite group of technology pioneers actively working to solve some of the industry's most persistent challenges.

A New Standard in Pharmacy Cost Control

For years, employers, health plans, and other pharmacy benefit stakeholders have grappled with a fundamental flaw in cost management: a reliance on retrospective data. Reports would arrive months after spending occurred, offering a historical snapshot of costs but little power to influence them proactively. Xevant was founded to dismantle this reactive model.

The company’s approach moves beyond static reports, enabling real-time, operational decision-making designed to achieve the lowest possible net pharmacy cost. At the heart of this innovation is VerX, Xevant’s proprietary AI-driven orchestration platform. VerX functions as an intelligent engine, continuously analyzing vast and complex streams of pharmacy data to surface hidden inefficiencies, prioritize cost-saving actions, and guide strategic decisions. The platform scrutinizes every facet of the pharmacy benefit landscape, including Pharmacy Benefit Manager (PBM) contracts, drug formularies, pharmacy channel performance, and the notoriously expensive specialty drug category.

By providing timely interventions instead of just delayed insights, the platform empowers organizations to manage cost drivers with unprecedented accountability and minimal disruption to members. This shift from passive analysis to active management is what distinguishes Xevant in the health tech space.

"Artificial intelligence only matters if it drives better decisions that lead to optimal performance," said Brandon Newman, CEO of Xevant, in a statement accompanying the announcement. "This recognition validates our focus on using AI to turn pharmacy data into action—helping organizations actively manage cost and complexity in real time, not months after the fact."

The Business Case for Real-Time AI

The financial implications of this technological shift are profound. With U.S. prescription drug spending continuing its relentless climb, organizations are desperate for tools that deliver a measurable return on investment. Xevant’s platform is engineered to provide just that, targeting the core inefficiencies that bloat pharmacy budgets.

Traditional methods often leave millions of dollars on the table due to missed rebate opportunities, suboptimal formulary design, or members utilizing high-cost drugs when more affordable, clinically effective alternatives are available. The VerX platform’s real-time analytics engine flags these opportunities as they happen, allowing benefits managers to intervene immediately. This could mean alerting a plan administrator to a surge in off-formulary prescriptions or identifying a network pharmacy with anomalous pricing patterns.

This level of proactive oversight fosters a new era of accountability for PBMs and other partners. By equipping clients with transparent, actionable data, Xevant helps them ensure that contract terms are being met and that cost-saving initiatives are being executed effectively. For employers and health plans, this translates directly into lower net costs, improved budget predictability, and the ability to offer more sustainable pharmacy benefits to their members and employees without sacrificing quality of care. The award from Modern Healthcare serves as an external validation of this powerful business case, confirming that the industry is taking notice of solutions that deliver tangible financial results.

A Prestigious Nod in a Competitive Field

Earning a Modern Healthcare Best in Business award is no small feat. The program is widely respected for its rigorous and impartial evaluation process. Entries are judged by a panel of senior-level industry experts, including active and retired leaders from top healthcare organizations and associations. These judges assess submissions based on a comprehensive set of criteria, including quality of the technology, demonstrable outcomes, operational efficiency, and the degree of innovation.

Xevant’s victory in the AI category places it in the company of other major technology players and disruptive innovators. In recent years, Modern Healthcare has recognized giants like Oracle and groundbreaking firms such as Xsolis and Medallion for their contributions to AI in healthcare. This context highlights the significance of Xevant’s achievement; it is not just an award but a signal that its specialized focus on the pharmacy benefits ecosystem is considered a best-in-class application of artificial intelligence.

This industry stamp of approval is critical in a crowded and often hyped-up health tech market. It helps decision-makers at health plans and large corporations cut through the noise and identify partners with proven, impactful solutions. For Xevant, the award serves as a powerful testament to its mission and a key differentiator in a competitive landscape where many companies claim to leverage AI, but few can point to such esteemed third-party validation.

AI's Growing Role in Taming Healthcare Complexity

The recognition of Xevant is emblematic of a larger, transformative trend: the maturation of AI from a theoretical concept into an indispensable tool for navigating the complexities of modern healthcare. The industry is burdened by administrative waste, fragmented data systems, and workforce shortages, all of which contribute to rising costs and clinician burnout. AI-powered solutions are emerging as a critical part of the answer.

Across the sector, AI is being deployed to automate burdensome administrative tasks, streamline clinical workflows, and improve the accuracy of medical necessity decisions. In the pharmacy benefits space, where data is both voluminous and notoriously siloed, AI’s ability to synthesize and analyze information in real time is particularly revolutionary.

However, the path to widespread adoption is not without its challenges. Integrating sophisticated AI platforms with legacy IT infrastructure can be a significant technical hurdle. Furthermore, ensuring data privacy and navigating the evolving regulatory landscape for AI in healthcare requires deep expertise and a commitment to ethical practices. Despite these obstacles, the momentum is undeniable. The clear potential for AI to drive down costs, enhance efficiency, and ultimately support better patient outcomes is too great to ignore. Xevant's award-winning approach, focused on turning complex data into clear, immediate action, exemplifies the practical and powerful application of this technology. It demonstrates that with the right focus, AI can deliver on its promise to not only provide insight but to orchestrate real, positive change in the healthcare system.